Skip to main content

Advertisement

Log in

Platelet-Rich Plasma for the Treatment of Low Back Pain: a Comprehensive Review

  • Hot Topics in Pain and Headache (N Rosen, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Back pain is a growing problem worldwide, incurring enormous economic costs and disability. Current treatment modalities often provide adequate relief but fail to address underlying conditions. Regenerative cellular modalities aim to restore anatomical function in degenerative conditions which may cause low back pain. Platelet-rich plasma (PRP) consists of an increased concentration of autologous platelets suspended in a small amount of plasma. PRP can be administered via injection or topically and is prepared using various techniques.

Recent Findings

While a unifying mechanism of action is not well understood, biochemical and cellular changes involved in inflammation and mechanical structure have been detected in both in vitro and in vivo studies. At a higher level, PRP injection research utilizing animal models and patient data have provided insights into pain relief, chondroprotection, and factors that impact the therapy’s efficacy. Recently, a small number of studies have promoted PRP injection as a relatively safe means of treating patients with degenerative disc disease who have failed other means of managing their lower back pain. PRP injections for sacroiliac joint–related pain are not an accepted or common treatment modality; the evidence for their efficacy remains to be seen outside of small RCTs and case reports. A small number of prospective trials have suggested there may be some benefit to using PRP injection in the treatment of pain or functional decline caused by facet joint arthropathy.

Summary

These commonly used modalities require further study to improve quality of evidence and to investigate the safety and efficacy of PRP injections for various common causes of chronic low back.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: data from the 2009-2010 National Health and Nutrition Examination Survey. Arthritis Care Res. 2016;68:1688–94.

    Article  Google Scholar 

  2. Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. BMJ Publishing Group Ltd; 2014;73:968–74.

    Article  Google Scholar 

  3. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum NIH Public Access; 2008;58:26–35.

    Article  Google Scholar 

  4. Grol-Prokopczyk H. Sociodemographic disparities in chronic pain, based on 12-year longitudinal data. Pain. 2017;158:313–22.

    Article  Google Scholar 

  5. Janevic MR, McLaughlin SJ, Heapy AA, Thacker C, Piette JD. Racial and socioeconomic disparities in disabling chronic pain: findings from the health and retirement study. J Pain. 2017;18:1459–67.

    Article  Google Scholar 

  6. Hestbaek L, Leboeuf-Yde C, Manniche C. Is low back pain part of a general health pattern or is it a separate and distinctive entity? A critical literature review of comorbidity with low back pain. J Manip Physiol Ther. 2003;26:243–52.

    Article  Google Scholar 

  7. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol. 2010;171:135–54.

    Article  Google Scholar 

  8. Martin BI, Deyo RA, Mirza SK, Turner JA, Comstock BA, Hollingworth W, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656–64.

    Article  CAS  Google Scholar 

  9. Rajaee SS, Bae HW, Kanim LEA, Delamarter RB. Spinal fusion in the United States. Spine (Phila Pa 1976). 2012;37:67–76.

    Article  Google Scholar 

  10. Guo HR, Tanaka S, Halperin WE, Cameron LL. Back pain prevalence in US industry and estimates of lost workdays. Am J Public Health. 1999;89:1029–35.

    Article  CAS  Google Scholar 

  11. Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Back pain exacerbations and lost productive time costs in United States workers. Spine (Phila Pa 1976). 2006;31:3052–60.

    Article  Google Scholar 

  12. Deyo RA, Mirza SK. Trends and variations in the use of spine surgery. Clin Orthop Relat Res. 2006;443:139–46.

    Article  Google Scholar 

  13. Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine (Phila Pa 1976). 2004;29:884–90; discussion 891.

    Article  Google Scholar 

  14. Friedly J, Chan L, Deyo R. Increases in lumbosacral injections in the Medicare population. Spine (Phila Pa 1976). 2007;32:1754–60.

    Article  Google Scholar 

  15. Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res Dove Press; 2016;9:457–67.

    Article  Google Scholar 

  16. Theis KA, Roblin DW, Helmick CG, Luo R. Prevalence and causes of work disability among working-age U.S. adults, 2011–2013, NHIS. Disabil Health J. 2018;11:108–15.

    Article  Google Scholar 

  17. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443–54.

    Article  CAS  Google Scholar 

  18. Sullivan MJ, Reesor K, Mikail S, Fisher R. The treatment of depression in chronic low back pain: review and recommendations. Pain. 1992;50:5–13.

    Article  CAS  Google Scholar 

  19. Porter LS, Keefe FJ, Wellington C, de Williams A. Pain communication in the context of osteoarthritis: patient and partner self-efficacy for pain communication and holding back from discussion of pain and arthritis-related concerns. Clin J Pain. 2008;24:662–8.

    Article  Google Scholar 

  20. Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344:363–70.

    Article  CAS  Google Scholar 

  21. O’Brien M. In: De Wald RL, Arlet V, Carl AL, O’Brien MF, editors. Spinal deformities: the comprehensive text. Stuttgart: Georg Thieme Verlag; 2003.

    Google Scholar 

  22. Garland EL. Pain processing in the human nervous system: a selective review of nociceptive and biobehavioral pathways. Prim Care NIH Public Access; 2012;39:561–71.

    Article  Google Scholar 

  23. Choi Y-S. Pathophysiology of degenerative disc disease. Asian Spine J. Korean Society of Spine Surgery; 2009;3:39–44.

    Article  Google Scholar 

  24. Takahashi M, Haro H, Wakabayashi Y, Kawa-uchi T, Komori H, Shinomiya K. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J Bone Joint Surg (Br). 2001;83:491–5.

    Article  CAS  Google Scholar 

  25. Varlotta GP, Brown MD, Kelsey JL, Golden AL. Familial predisposition for herniation of a lumbar disc in patients who are less than twenty-one years old. J Bone Joint Surg Am. 1991;73:124–8.

    Article  CAS  Google Scholar 

  26. Nachemson A, Lewin T, Maroudas A, Freeman MA. In vitro diffusion of dye through the end-plates and the annulus fibrosus of human lumbar inter-vertebral discs. Acta Orthop Scand. 1970;41:589–607.

    Article  CAS  Google Scholar 

  27. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine (Phila Pa 1976). 1995;20:1307–14.

    Article  CAS  Google Scholar 

  28. Roberts S, Evans EH, Kletsas D, Jaffray DC, Eisenstein SM. Senescence in human intervertebral discs. Eur Spine J. 2006;15:312–6.

    Article  Google Scholar 

  29. Miller JA, Schmatz C, Schultz AB. Lumbar disc degeneration: correlation with age, sex, and spine level in 600 autopsy specimens. Spine (Phila Pa 1976). 1988;13:173–8.

    Article  CAS  Google Scholar 

  30. Frymoyer JW. The adult spine : principles and practice. Philadelphia: Lippincott-Raven; 1997.

    Google Scholar 

  31. Yong-Hing K, Kirkaldy-Willis WH. The pathophysiology of degenerative disease of the lumbar spine. Orthop Clin N Am. 1983;14:491–504.

    CAS  Google Scholar 

  32. Wang H-L, Avila G. Platelet rich plasma: myth or reality? Eur J Dent Dental Investigations Society; 2007;1:192–4.

  33. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg. 1993;165:728–37.

    Article  CAS  Google Scholar 

  34. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999;14:529–35.

    CAS  Google Scholar 

  35. Dhillon MS, Behera P, Patel S, Shetty V. Orthobiologics and platelet rich plasma. Indian J Orthop Wolters Kluwer -- Medknow Publications; 2014;48:1–9.

    Article  Google Scholar 

  36. Crane D, Everts P. Platelet rich plasma (PRP) matrix graft. Pract Pain Manag. 2008;8.

  37. Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, et al. Knee osteoarthritis injection choices: platelet- rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 2015;8:CMAMD.S17894.

    Article  Google Scholar 

  38. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158–67.

    Article  CAS  Google Scholar 

  39. Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Ski Appendage Disord. Karger Publishers; 2018;4:18–24.

    Article  Google Scholar 

  40. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638–46.

    Article  CAS  Google Scholar 

  41. Badran KW, Nabili V. Lasers, microneedling, and platelet-rich plasma for skin rejuvenation and repair. Facial Plast Surg Clin N Am. 2018;26:455–68.

    Article  Google Scholar 

  42. Lynch MD, Bashir S. Applications of platelet-rich plasma in dermatology: a critical appraisal of the literature. J Dermatolog Treat. 2016;27:285–9.

    Article  CAS  Google Scholar 

  43. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13:1185–95.

    Article  CAS  Google Scholar 

  44. Franchini M, Cruciani M, Mengoli C, Marano G, Pupella S, Veropalumbo E, et al. Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis. Blood Transfus. 2018;16:502–13.

    PubMed  PubMed Central  Google Scholar 

  45. Andriolo L, Di Matteo B, Kon E, Filardo G, Venieri G, Marcacci M. PRP augmentation for ACL reconstruction. Biomed Res Int Hindawi; 2015;2015:371746.

    Article  Google Scholar 

  46. Li F, Li Y, Qiao C, Zhu J, Chen J, Zhang P. Topical use of platelet-rich plasma can improve the clinical outcomes after total knee arthroplasty: a systematic review and meta-analysis of 1316 patients. Int J Surg. 2017;38:109–16.

    Article  Google Scholar 

  47. De Souza L, Oliver Frank A. Patients’ experiences of the impact of chronic back pain on family life and work. Disabil Rehabil. 2011;33:310–8.

    Article  Google Scholar 

  48. la FP, Argáez C. Platelet-rich plasma injections for wound healing and tissue rejuvenation: a review of clinical effectiveness, cost-effectiveness and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2017.

    Google Scholar 

  49. Wasserman A, Matthewson G, MacDonald P. Platelet-rich plasma and the knee—applications in orthopedic surgery. Curr Rev Musculoskelet Med. 2018;11:607–15.

    Article  Google Scholar 

  50. Muchedzi TA, Roberts SB. A systematic review of the effects of platelet rich plasma on outcomes for patients with knee osteoarthritis and following total knee arthroplasty. Surgeon. 2018;16:250–8.

    Article  Google Scholar 

  51. Wang S, Chang Q, Lu J, Wang C. Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration. Int Orthop Springer Berlin Heidelberg; 2015;39:927–34.

    Article  Google Scholar 

  52. Tohidnezhad M, Bayer A, Rasuo B, Hock JVP, Kweider N, Fragoulis A, et al. Platelet-released growth factors modulate the secretion of cytokines in synoviocytes under inflammatory joint disease. Mediators Inflamm Hindawi; 2017;2017:1–9.

    Article  Google Scholar 

  53. Khalaf K, Nikkhoo M, Kuo Y-W, Hsu Y-C, Parnianpour M, Campbell-Kyureghyan N, et al. Recovering the mechanical properties of denatured intervertebral discs through platelet-rich plasma therapy. 2015 37th Annu Int Conf IEEE Eng Med Biol Soc. IEEE; 2015. p. 933–6.

  54. Yang F, Hu H, Yin W, Li G, Yuan T, Xie X, et al. Autophagy is independent of the chondroprotection induced by platelet-rich plasma releasate. Biomed Res Int Hindawi; 2018;2018:1–11.

    Google Scholar 

  55. Khatab S, van Buul GM, Kops N, Bastiaansen-Jenniskens YM, Bos PK, Verhaar JA, et al. Intra-articular injections of platelet-rich plasma releasate reduce pain and synovial inflammation in a mouse model of osteoarthritis. Am J Sports Med. SAGE PublicationsSage CA: Los Angeles; 2018;46:977–86.

  56. Yung Y-L, Fu S-C, Cheuk Y-C, Qin L, Ong MT-Y, Chan K-M, et al. Optimisation of platelet concentrates therapy: composition, localisation, and duration of action. Asia-Pacific J Sport Med Arthrosc Rehabil Technol Elsevier; 2017;7:27–36.

    Article  Google Scholar 

  57. Mohammed S, Yu J. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. J Spine Surg. 2018;4:115–22.

    Article  Google Scholar 

  58. Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop International Orthopaedics; 2016;40:1321–8.

    Article  Google Scholar 

  59. Chang RG, Hurwitz NR, Harrison JR, C J, Lutz GE. Ankylosing spondylitis versus internal disc disruption: a case report treated successfully with intradiscal platelet-rich plasma injection. Spine Res iMedPub; 2017;3.

  60. Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial. Pain Med. 2015;17:pnv053.

    Article  Google Scholar 

  61. Von Korff M, Jensen MP, Karoly P. Assessing global pain severity by self-report in clinical and health services research. Spine (Phila Pa 1976). 2000;25:3140–51.

    Article  Google Scholar 

  62. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25:2940–52 discussion 2952.

    Article  CAS  Google Scholar 

  63. Ostelo RWJG, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, et al. Interpreting change scores for pain and functional status in low back pain. Spine (Phila Pa 1976). 2008;33:90–4.

    Article  Google Scholar 

  64. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–58.

    Article  CAS  Google Scholar 

  65. Akeda K, Ohishi K, Masuda K, Bae WC, Takegami N, Yamada J, et al. Intradiscal injection of autologous platelet-rich plasma Releasate to treat discogenic low back pain: a preliminary clinical trial. Asian Spine J. 2017;11:380–9.

    Article  Google Scholar 

  66. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 2001;26:1873–8.

    Article  CAS  Google Scholar 

  67. Akeda K, Yamada T, Inoue N, Nishimura A, Sudo A. Risk factors for lumbar intervertebral disc height narrowing: a population-based longitudinal study in the elderly. BMC Musculoskelet Disord. 2015;16:344.

    Article  Google Scholar 

  68. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, et al. Lumbar Intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R. 2016;8:1–10.

    Article  Google Scholar 

  69. Feise RJ, Michael Menke J. Functional rating index: a new valid and reliable instrument to measure the magnitude of clinical change in spinal conditions. Spine (Phila Pa 1976). 2001;26:78–86 discussion 87.

    Article  CAS  Google Scholar 

  70. Jenkinson C, Layte R, Coulter A, Wright L. Evidence for the sensitivity of the SF-36 health status measure to inequalities in health: results from the Oxford healthy lifestyles survey. J Epidemiol Community Health BMJ Publishing Group Ltd; 1996;50:377–80.

    Article  CAS  Google Scholar 

  71. Haefeli M, Elfering A. Pain assessment. Eur Spine J Springer; 2006;15 Suppl 1:S17–24.

    Article  Google Scholar 

  72. Schofferman J, Anderson D, Hines R, Smith G, White A. Childhood psychological trauma correlates with unsuccessful lumbar spine surgery. Spine (Phila Pa 1976). 1992;17:S138–44.

    Article  CAS  Google Scholar 

  73. Simopoulos TT, Manchikanti L, Gupta S, Aydin SM, Kim CH, Solanki D, et al. Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 2015;18:E713–56.

    PubMed  Google Scholar 

  74. Singla V, Batra YK, Bharti N, Goni VG, Marwaha N. Steroid vs. platelet-rich plasma in ultrasound-guided sacroiliac joint injection for chronic low back pain. Pain Pract. 2017;17:782–91.

    Article  Google Scholar 

  75. Ko GD, Mindra S, Lawson GE, Whitmore S, Arseneau L. Case series of ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction. J Back Musculoskelet Rehabil. 2017;30:363–70.

    Article  Google Scholar 

  76. Kalichman L, Hunter DJ. Lumbar facet joint osteoarthritis: a review. Semin Arthritis Rheum WB Saunders; 2007;37:69–80.

    Article  Google Scholar 

  77. Doherty M. In: Hunter D, Curtis MR, editors. Clinical manifestations and diagnosis of osteoarthritis. Waltham: UpToDate; 2017.

    Google Scholar 

  78. Wu J, Du Z, Lv Y, Zhang J, Xiong W, Wang R, et al. A new technique for the treatment of lumbar facet joint syndrome using intra-articular injection with autologous platelet rich plasma. Pain Physician. 19:617–25.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Urits.

Ethics declarations

Conflict of Interest

Ivan Urits, Omar Viswanath, Annemarie C. Galasso, Emily R. Sottosani, Keenan M. Mahan, Christopher M. Aiudi, and Vwaire J. Orhurhu declare no conflict of interest.

Alan D. Kaye discloses that he is on the Speakers Bureau for Depomed, Inc., and Merck.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Hot Topics in Pain and Headache

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Urits, I., Viswanath, O., Galasso, A.C. et al. Platelet-Rich Plasma for the Treatment of Low Back Pain: a Comprehensive Review. Curr Pain Headache Rep 23, 52 (2019). https://doi.org/10.1007/s11916-019-0797-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-019-0797-6

Keywords

Navigation